Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate (Anplag) in PAD Patients with Hyperviscosity
NCT03509922Phase 4Completed
- Sponsor
- Yuhan
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sarpogrelate in peripheral artery disease (PAD), sponsored by Yuhan. Started Oct 2018; status: completed.
02
Drugs
sarpogrelate
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT03509922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03509922.